Novel Schiff base-Pt(ii) complexes: inhibition of Aβ aggregation via histidine interaction
| dc.contributor.author | Irisli, Sevil | |
| dc.contributor.author | Dogan, Umut | |
| dc.contributor.author | Gunnaz, Salih | |
| dc.contributor.author | Yurt, Fatma | |
| dc.contributor.author | Sahin, Onur | |
| dc.date.accessioned | 2026-04-25T14:20:05Z | |
| dc.date.available | 2026-04-25T14:20:05Z | |
| dc.date.issued | 2026 | |
| dc.department | Sinop Üniversitesi | |
| dc.description.abstract | In this study, three Schiff base ligands (L1-L3) and their novel platinum(ii) complexes (I-III) were synthesized and characterized using FT-IR, NMR, and elemental analysis. The crystal structure of complex I was determined by X-ray crystallography, while the lipophilicity of the complexes was evaluated by UV-Vis spectroscopy. The ability of the compounds to inhibit A beta aggregation was assessed using the SH-SY5Y human neuroblastoma cell line. Due to its high cytotoxicity, comparable to that of cisplatin, complex II was excluded from further biological investigations. The kinetics of A beta aggregation inhibition were examined fluorometrically using Thioflavin-T, and the binding interactions of the complexes with the A beta 1-42 sequence were elucidated through studies of their interactions with l-histidine using 1H-NMR and LC/QTOF/MS analyses. The results demonstrate that complexes I and III significantly suppress A beta fibril formation, with IC50 values of 50 mu M and 25 mu M, respectively. The enhanced biological activity is attributed to the strong electron-donating properties of the ligand substituents. Overall, these findings reveal that the synthesized complexes effectively inhibit A beta amyloid aggregation and promote cell viability. | |
| dc.identifier.doi | 10.1039/d5nj04180e | |
| dc.identifier.endpage | 1138 | |
| dc.identifier.issn | 1144-0546 | |
| dc.identifier.issn | 1369-9261 | |
| dc.identifier.issue | 2 | |
| dc.identifier.orcid | 0000-0002-7422-6593 | |
| dc.identifier.orcid | 0000-0002-9394-6908 | |
| dc.identifier.scopus | 2-s2.0-105025230160 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 1125 | |
| dc.identifier.uri | https://doi.org/10.1039/d5nj04180e | |
| dc.identifier.uri | https://hdl.handle.net/11486/8348 | |
| dc.identifier.volume | 50 | |
| dc.identifier.wos | WOS:001643910100001 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Royal Soc Chemistry | |
| dc.relation.ispartof | New Journal of Chemistry | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20260420 | |
| dc.subject | #BAŞV! | |
| dc.title | Novel Schiff base-Pt(ii) complexes: inhibition of Aβ aggregation via histidine interaction | |
| dc.type | Article |












